BioAllergenix, an emerging industry leader in holistic and alternative health care, announced that Joshua Kayne has joined the company in the newly created position of Executive Vice President where he is directly responsible for the company’s global sales and marketing. In this role, Kayne will lead the strategic planning for BioAllergenix’s vision and growth as it expands its mindshare among both physicians and patients in this market.
The BAX-3000 by BioAllergenix is the only fully-automated L.A.S.E.R (Light and Sound Energy Relaxation Therapy) system that combines neurological (SSSR) substance specific stress reduction and environmental substance exposure to reduce or eliminate inappropriate ANS Mediated Responses.
BioAllergenix is pleased to announce the appointment of Dr. Guy Annunziata to the position of Chief Medical Officer. He comes to BioAllergenix after an impressive career in chiropractic care, practice management and academic instruction.